XML 19 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
4. STOCK-BASED COMPENSATION
9 Months Ended
Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
STOCK-BASED COMPENSATION

Stock-based compensation costs recognized during the quarters ended March 31, 2017 and 2016 amounted to $44,310 and $51,705 respectively, and the costs were included in the accompanying consolidated statements of operations in: selling, general and administrative expenses (2017 - $28,949; 2016 $33,721), research and development expenses (2017 - $6,692, 2016 - $9,316) and cost of goods sold (2017 - $8,669; 2016 - $8,668). Stock-based compensation costs recognized during the nine month periods ended March 31, 2017 and 2016 amounted to $154,743 and $194,133, respectively, and were included in the accompanying consolidated statements of operations in: selling, general and administrative expenses (2017 - $106,035; 2016 - $94,099), research and development expenses (2017 - $22,701, 2016 - $48,023) and cost of goods sold (2017 - $26,007, 2016 - $52,011). No compensation has been capitalized because such amounts would have been immaterial.

 

The following tables summarize stock option activity for the nine months ended March 31, 2017:

 

   Options Outstanding
   Number of
Shares
   Weighted Average
Exercise Price
   Weighted Average
Contractual Life
Outstanding at June 30, 2016   1,136,000   $0.79   7.74 years
Cancellations   (4,600)  $2.65    
Outstanding at March 31, 2017   1,131,400   $0.78   7.25 years

   

Information related to the stock options outstanding as of March 31, 2017 is as follows:

 

Range of Exercise
Prices
  Number of
Shares
   Weighted-
Average
Remaining
Contractual Life
(years)
   Weighted-
Average
Exercise
Price
   Exercisable
Number of
Shares
   Exercisable
Weighted-
Average
Exercise
Price
 
$0.27    40,000    4.29   $0.27    40,000   $0.27 
$0.48    60,000    9.00   $0.48    40,000   $0.48 
$0.50    80,000    9.23   $0.50    35,000   $0.50 
$0.50    20,000    4.22   $0.50    20,000   $0.50 
$0.55    37,000    4.87   $0.55    37,000   $0.55 
$0.73    600,000    8.13   $0.73    400,000   $0.73 
$0.85    9,000    5.76   $0.85    9,000   $0.85 
$0.90    9,000    6.76   $0.90    9,000   $0.90 
$0.95    65,000    7.28   $0.95    65,000   $0.95 
$1.20    207,800    4.92   $1.20    207,800   $1.20 
$1.25    1,200    1.65   $1.25    1,200   $1.25 
$1.35    1,200    2.65   $1.35    1,200   $1.35 
$7.75    1,200    0.66   $7.75    1,200   $7.75 
$0.27–$7.75    1,131,400    7.25   $0.78    866,400   $0.82 

 

The aggregate intrinsic value of the Company’s “in-the-money” outstanding and exercisable options as of March 31, 2017 was $5,500.